Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

  • Quoted phrase not found.
1.

Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.

Madsen CV, Bundgaard H, Rasmussen ÅK, Sørensen SS, Petersen JH, Køber L, Feldt-Rasmussen U, Petri H.

Scand Cardiovasc J. 2017 Aug;51(4):207-216. doi: 10.1080/14017431.2017.1332383. Epub 2017 May 25.

PMID:
28545342
2.

Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.

Guo X, Fan C, Wang Y, Wang M, Cai C, Yang Y, Zhao S, Duan F, Li Y.

Medicine (Baltimore). 2017 Mar;96(11):e6249. doi: 10.1097/MD.0000000000006249.

3.

Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.

Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH.

Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005311. doi: 10.1161/CIRCIMAGING.116.005311.

PMID:
28193612
4.

Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.

Ntusi NA, Shaboodien G, Badri M, Gumedze F, Mayosi BM.

Cardiovasc J Afr. 2016 May/Jun;27(3):152-158. doi: 10.5830/CVJA-2015-075.

5.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
6.

Identification of Two Novel LAMP2 Gene Mutations in Danon Disease.

Csányi B, Popoiu A, Hategan L, Hegedűs Z, Nagy V, Rácz K, Hőgye M, Sághy L, Iványi B, Csanády M, Forster T, Sepp R.

Can J Cardiol. 2016 Nov;32(11):1355.e23-1355.e30. doi: 10.1016/j.cjca.2016.02.071. Epub 2016 Mar 4.

PMID:
27179547
7.

Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.

Peyrou J, Réant P, Reynaud A, Cornolle C, Dijos M, Rooryck-Thambo C, Landelle M, Montaudon M, Laurent F, Roudaut R, Lafitte S.

Int J Cardiovasc Imaging. 2016 Sep;32(9):1379-1389. Epub 2016 Jun 20.

PMID:
27324645
8.

Combined Heart and Liver Transplantation: The Cedars-Sinai Experience.

Reich HJ, Awad M, Ruzza A, De Robertis MA, Ramzy D, Nissen N, Colquhoun S, Esmailian F, Trento A, Kobashigawa J, Czer LS.

Transplant Proc. 2015 Nov;47(9):2722-6. doi: 10.1016/j.transproceed.2015.07.038.

PMID:
26680081
9.

Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

Jensen MK, Havndrup O, Christiansen M, Andersen PS, Axelsson A, Køber L, Bundgaard H.

Int J Cardiovasc Imaging. 2015 Dec;31(8):1511-8. doi: 10.1007/s10554-015-0723-x. Epub 2015 Aug 1.

PMID:
26231341
10.

Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.

Wu W, Lu CX, Wang YN, Liu F, Chen W, Liu YT, Han YC, Cao J, Zhang SY, Zhang X.

J Am Heart Assoc. 2015 Jul 10;4(7). pii: e001879. doi: 10.1161/JAHA.115.001879.

11.

Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.

Nomura A, Konno T, Fujita T, Tanaka Y, Nagata Y, Tsuda T, Hodatsu A, Sakata K, Nakamura H, Kawashiri MA, Fujino N, Yamagishi M, Hayashi K.

Circ J. 2015;79(1):136-43. doi: 10.1253/circj.CJ-14-0822. Epub 2014 Nov 7.

12.

Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.

Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM.

Heart. 2015 Feb;101(4):294-301. doi: 10.1136/heartjnl-2014-306387. Epub 2014 Oct 28.

13.

Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life.

Weber R, Kantor P, Chitayat D, Friedberg MK, Golding F, Mertens L, Nield LE, Ryan G, Seed M, Yoo SJ, Manlhiot C, Jaeggi E.

JACC Heart Fail. 2014 Aug;2(4):403-11. doi: 10.1016/j.jchf.2014.02.010. Epub 2014 Jul 9.

PMID:
25023818
14.

Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Bratt EL, Östman-Smith I.

Cardiol Young. 2015 Mar;25(3):501-10. doi: 10.1017/S1047951114000237. Epub 2014 Mar 10.

15.

Factors predicting long-term mortality in patients with hypertrophic cardiomyopathy.

Bostan C, Sinan UY, Canbolat P, Abaci O, Munipoglu SK, Kucukoglu S.

Echocardiography. 2014 Oct;31(9):1056-61. doi: 10.1111/echo.12537. Epub 2014 Feb 8.

PMID:
24506463
16.

Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.

Forsey J, Benson L, Rozenblyum E, Friedberg MK, Mertens L.

J Am Soc Echocardiogr. 2014 Feb;27(2):215-21. doi: 10.1016/j.echo.2013.10.012. Epub 2013 Dec 8.

PMID:
24325958
17.

Nonobstructive hypertrophic cardiomyopathy with left ventricular aneurysm: the role of cardiac magnetic resonance.

Luni FK, Moza A, Sheikh M, Coker MF, Chaganti SK, Lewis TJ, Kanjwal Y.

Tex Heart Inst J. 2013;40(4):465-7.

18.

Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.

Anastasakis A, Theopistou A, Rigopoulos A, Kotsiopoulou C, Georgopoulos S, Fragakis K, Sevdalis E, Stefanadis C.

Hellenic J Cardiol. 2013 Jul-Aug;54(4):281-8.

19.

Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.

Meyer T, Pankuweit S, Richter A, Maisch B, Ruppert V.

Gene. 2013 Sep 15;527(1):416-20. doi: 10.1016/j.gene.2013.06.025. Epub 2013 Jun 29.

PMID:
23816408
20.

Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.

Núñez L, Gimeno-Blanes JR, Rodríguez-García MI, Monserrat L, Zorio E, Coats C, McGregor CG, Hernandez del Rincón JP, Castro-Beiras A, Hermida-Prieto M.

Circ J. 2013;77(9):2358-65. Epub 2013 Jun 19.

Supplemental Content

Loading ...
Support Center